The latest market report published by Credence Research, Inc. The United States Parenteral Nutrition market is witnessing substantial growth, with significant market values and a steady growth rate. In 2022, the market was valued at USD 1,908.05 million, indicating a robust presence in the healthcare sector. The market is projected to grow significantly, with an estimated USD 3,266.23 million by 2030. This growth trajectory reflects a Compound Annual Growth Rate (CAGR) of 6.66% from 2023 to 2030.
Parenteral nutrition, also known as intravenous or IV nutrition, is a medical therapy that delivers essential nutrients directly into a patient’s bloodstream when they are unable to consume food or absorb nutrients through their digestive system. In the United States, the parenteral nutrition market has been steadily growing due to various factors, including an aging population, the increasing prevalence of chronic diseases, and advancements in healthcare technology.
Market Size and Growth
The United States parenteral nutrition market has witnessed significant growth in recent years. According to industry reports, the market was valued at approximately $2.5 billion in 2020 and is expected to continue its upward trajectory in the coming years. This growth can be attributed to the rising incidence of gastrointestinal disorders, cancer, and other chronic illnesses that often require specialized nutrition support.
Browse the Full Report: https://www.credenceresearch.com/report/united-states-parenteral-nutrition-market
Key Drivers
- Aging Population: As the U.S. population continues to age, the demand for parenteral nutrition is likely to increase. Elderly individuals may experience difficulty in swallowing or have reduced nutrient absorption, making parenteral nutrition a crucial component of their healthcare.
- Chronic Diseases: The prevalence of chronic diseases such as cancer, Crohn’s disease, and cystic fibrosis has been on the rise. These conditions often necessitate parenteral nutrition to meet the nutritional needs of patients undergoing treatment or suffering from severe malnutrition.
- Technological Advancements: Advances in medical technology have led to improved formulations and delivery methods for parenteral nutrition. These innovations have made parenteral nutrition more accessible, safer, and better tolerated by patients.
Challenges
While the United States parenteral nutrition market is poised for growth, it faces certain challenges. The cost of parenteral nutrition therapy can be substantial, and reimbursement policies may not always cover the full expenses. Additionally, there is a need for healthcare providers to ensure proper training and education for the administration of parenteral nutrition to avoid complications.
Market Players
Several companies play a significant role in the United States parenteral nutrition market. Leading manufacturers and suppliers include Fresenius Kabi, B. Braun Melsungen AG, Baxter International Inc., and Grifols, among others. These companies continue to invest in research and development to improve the safety and efficacy of parenteral nutrition products.
The United States parenteral nutrition market is experiencing steady growth due to an aging population, the increasing prevalence of chronic diseases, and technological advancements. As the demand for parenteral nutrition continues to rise, it is essential for healthcare providers, manufacturers, and policymakers to work together to ensure accessibility, affordability, and safety in the delivery of this critical medical therapy. With ongoing research and development, the future of parenteral nutrition in the United States looks promising, offering hope for patients in need of specialized nutritional support.
Browse the Full Report: https://www.credenceresearch.com/report/united-states-parenteral-nutrition-market
List of Companies Covered:
- Baxter
- Otsuka Pharmaceutical Factory, Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Grifols S.A
- Pfizer, Inc.
- Actavis, Inc.
- Aculife (Nirlife)
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Hospira, Inc.
- Vifor Pharma
By Segmentation Type
By Nutrient Type
- Single Dose Amino Acid Solution
- Parenteral Lipid Emulsion
- Carbohydrates
- Trace Elements,
- Vitamins & Minerals
By Geography Type
- North America (U.S. and Rest of North America)
- Europe (U.K., Germany, France, and Rest of Europe)
- Asia Pacific (Japan, China, India, and Rest of Asia Pacific)
- Rest of World (Middle East & Africa (MEA), Latin America)
Contact Us:
Office No 3 Second Floor,
Abhilasha Bhawan, Pinto Park,
Gwalior [M.P]
474005 India
Phone: +91 6232 49 3207
Email: sales@credenceresearch.com
Visit: https://www.credenceresearch.com
